OCUGEN, INC. Due to Related Parties, Noncurrent
OCUGEN, INC. (OCGN) had Due to Related Parties, Noncurrent of $1.13 million as of 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Notes
us-gaap:DueToRelatedPartiesNoncurrent · last filed 2019-08-09
- 2019-06-30: Due to Related Parties, Noncurrent $1.13M.
- 2019-03-31: Due to Related Parties, Noncurrent $1.13M.
- 2018-12-31: Due to Related Parties, Noncurrent $1.13M.
- 2018-09-30: Due to Related Parties, Noncurrent $3.04M.
| Period end | Due to Related Parties, Noncurrent |
|---|---|
| 2019-06-30 | $1.13M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.13M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $1.13M 10-Q · filed 2019-08-09 |
| 2018-09-30 | $3.04M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.04M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $3.04M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.04M 10-K · filed 2019-03-22 |
| 2017-09-30 | $3.04M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.04M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $3.04M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $3.04M 10-K · filed 2018-03-15 |
| 2016-09-30 | $2.80M 10-Q · filed 2016-11-10 |
| 2015-12-31 | $1.55M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |